Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
leuprolide (lupron) (2021)
fp-025 (4 trials)
leuprolide (lupron) (4 trials)
fp-045 (2 trials)
Anemia (Phase 2)
Asthma (Phase 2)
Carcinoma (Phase 3)
Fanconi Anemia (Phase 2)
Fanconi Syndrome (Phase 2)
Inflammation (Phase 2)
Prostatic Neoplasms (Phase 3)
Trials (10 total)
Trial APIs (3 total)